Glossary · Medicines and conditions

What is an oromucosal?

Oromucosal

Applied to the mucous membranes of the mouth. Sativex is an oromucosal spray, meaning it is sprayed inside the cheek or under the tongue for absorption through the mouth lining.

Related terms

  • Sativex (Nabiximols)

    An oromucosal spray containing THC (2.7mg) and CBD (2.5mg) per spray in a 1:1 ratio. The only licensed cannabis-based medicine for MS-related spasticity in the UK. NHS-funded for qualifying MS patients who pass an initial trial.

  • CINV (Chemotherapy-Induced Nausea and Vomiting)

    Nausea and vomiting caused by cancer chemotherapy. A well-evidenced indication for cannabinoid medicines including nabilone.

  • Dravet Syndrome

    A severe form of epilepsy beginning in infancy, associated with frequent and prolonged seizures. Epidyolex (CBD oral solution) is NICE-approved and NHS-funded for this condition.

  • Epidyolex

    A pharmaceutical-grade CBD oral solution. The only fully licensed cannabis-based medicine in the UK with NICE approval. Indicated for seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in patients aged 2 and above. NHS-funded.

  • Lennox-Gastaut Syndrome (LGS)

    A severe form of childhood-onset epilepsy characterised by multiple seizure types and intellectual disability. Epidyolex is NICE-approved and NHS-funded for this condition.

This is a plain-language definition for general understanding, not medical or legal advice.

All 101 terms